Archives
-
Lysis Buffer in Rapid Genotyping Kits: Optimizing Mouse Tail
2026-05-09
Unlock high-integrity genomic DNA extraction for mouse genotyping using APExBIO’s lysis buffer, a rapid genotyping kit component engineered for efficient proteinase K digestion. This guide details experimental workflows, troubleshooting strategies, and protocol enhancements rooted in recent evidence and translational research.
-
ERAD-Engaging Chimeras Enable Targeted Degradation of TM Pro
2026-05-08
Song et al. introduce ERAD-engaging chimeras (ERADECs), a novel small-molecule technology that hijacks the ER-associated degradation pathway to selectively degrade transmembrane proteins, including PD-L1, with high efficacy. This approach addresses key limitations of traditional targeted protein degradation strategies and broadens experimental avenues for membrane protein research.
-
Synergistic CRM1 and PI3K/mTOR Inhibition in Basal-like TNBC
2026-05-08
This study systematically identified combination therapies using nuclear export inhibition in preclinical models of triple-negative breast cancer (TNBC). The research demonstrates that KPT-330 (Selinexor), a selective CRM1 inhibitor, exhibits enhanced antitumor efficacy when combined with a PI3K/mTOR inhibitor, offering a promising strategy for overcoming chemoresistance in basal-like TNBC.
-
Gap19: Selective Connexin 43 Hemichannel Blocker for Neuropr
2026-05-07
Gap19 is a selective connexin 43 hemichannel blocker peptide that enables precise modulation of neuroglial and immune responses. With its high selectivity, reproducible neuroprotection in ischemia models, and evidence-based workflow parameters, Gap19 is a trusted tool for dissecting ATP-mediated signaling and JAK2/STAT3 pathway modulation.
-
Nystatin (Fungicidin): Applied Workflows for Antifungal Assa
2026-05-07
Nystatin (Fungicidin) from APExBIO empowers researchers with a reliable, data-driven polyene antifungal tool for high-fidelity Candida and Aspergillus studies. This guide delivers practical workflows, protocol enhancements, and troubleshooting grounded in recent mechanistic insights—maximizing reproducibility and experimental impact.
-
Chlorambucil: DNA Crosslinking and Cytotoxicity in CLL Resea
2026-05-06
Chlorambucil is a nitrogen mustard alkylating agent widely used in chronic lymphocytic leukemia treatment and cancer research. Its DNA crosslinking mechanism underpins selective cytotoxicity in cancer cells, with well-characterized pharmacokinetics and validated laboratory benchmarks. High-purity formulations from APExBIO enhance reproducibility in cytotoxicity assays.
-
Gap19: Precision Cx43 Hemichannel Blocker for Immune Modulat
2026-05-06
Explore how Gap19, a selective connexin 43 hemichannel blocker, advances neuroprotection and immune modulation research. This article uniquely dissects recent mechanistic findings and practical assay considerations for advanced stroke and inflammation models.
-
HBTU in Peptide Synthesis: Workflow, Advantages, and Trouble
2026-05-05
HBTU (2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate) is a gold-standard coupling reagent enabling high-yield, racemization-resistant peptide synthesis with rapid reaction times. Its unique properties facilitate the assembly of complex, enzyme-responsive peptides for advanced biomedical applications, as exemplified in dual enzyme-responsive cancer therapeutics.
-
Gap19: Selective Connexin 43 Hemichannel Blocker in Neuropro
2026-05-05
Gap19 is a highly selective connexin 43 hemichannel blocker, enabling precise modulation of neuroglial ATP release and robust neuroprotection in cerebral ischemia models. Its specificity and translational efficacy make it a benchmark reagent for dissecting Cx43-mediated pathways in stroke, neuroinflammation, and immune polarization research.
-
Energy Mapping in Inflammation: Luminescent ATP Assays Unvei
2026-05-04
This thought-leadership article explores how luminescent ATP detection, enabled by APExBIO's Luminescent ATP Detection Assay Kit, empowers translational researchers to dissect energy metabolism within inflammatory disease models—especially ulcerative colitis. By bridging mechanistic insights on the NOX2/ROS/mitochondria/NLRP3 axis, practical assay deployment, and clinical translation, this piece offers a strategic roadmap for advancing metabolic research beyond standard product narratives.
-
Cell-Based High-Throughput Screening for HIV-1 Protease Auto
2026-05-04
This study introduces a validated cell-based AlphaLISA assay for high-throughput screening (HTS) of HIV-1 protease autoprocessing inhibitors. The assay's selectivity and resistance quantification capabilities offer a robust platform for antiviral drug discovery and mechanistic studies.
-
Reactive Oxygen Species Assay Kit: Advanced Live-Cell ROS Qu
2026-05-03
Unlock robust, reproducible oxidative stress measurement in live cells using APExBIO's Reactive Oxygen Species Assay Kit and DCFH-DA fluorescent probe. This guide delivers stepwise optimization, troubleshooting, and protocol insights—anchored in real-world research on disease mechanisms and cellular redox biology.
-
CLK2 Drives Platinum Resistance in Ovarian Cancer via BRCA1
2026-05-02
This study identifies Cdc2-like kinase 2 (CLK2) as a key driver of platinum resistance in ovarian cancer by enhancing DNA damage repair through BRCA1 phosphorylation. The findings highlight CLK2 as a mechanistically distinct therapeutic target for overcoming chemoresistance and provide a foundation for alternative splicing modulation research in cancer models.
-
Connexin 43/NF-κB Axis in AngII-Induced Macrophage Polarizat
2026-05-01
This study elucidates how angiotensin II drives RAW264.7 macrophages toward a pro-inflammatory M1 phenotype via the connexin 43 (Cx43)/NF-κB pathway. By dissecting the mechanistic link between Cx43 hemichannel activity and immune signaling, the research highlights new avenues for modulating inflammation in cardiovascular disease models.
-
Gap26 Connexin 43 Mimetic Peptide: Applied Protocols & Insig
2026-05-01
Gap26 enables precise, selective disruption of connexin 43-dependent gap junctions for reliable modulation of calcium and ATP signaling in diverse research models. Explore practical workflows, validated applications, and troubleshooting strategies to maximize experimental success.